Kenvue is assisted by Prevas’ expertise in project management and technology
During 2023, the pharmaceutical company Johnson & Johnson’s Consumer Business underwent a spin-off into a separate legal entity known as Kenvue through an IPO process. Prevas was entrusted with project management for the migration of IT applications for Kenvue's pharmaceutical factory in Helsingborg, McNeil AB, and also contributed specialists for technical support throughout the process. The division towards Kenvue, kicked-off a process known as the Diamond Project, commenced in the spring of 2022. Johnson & Johnson retains the Pharmaceutical and MedTech business, while the newly